Skip to content

Ageless Fund®

Ageless Fund® develops investment research products and invests in companies advancing artificial intelligence, healthcare, biotechnology, and human longevity. Its primary product is the Ageless Fund Research Platform, built to help investors research markets, monitor stocks, and make more informed decisions.

Ageless Fund Research Platform

Daily market research for self-directed growth investors.

Understand market health, identify leading trends, monitor your watchlists, and track catalysts, sentiment, and news—all in one streamlined platform.

Investments

Biotechnology

Auctus Biologics, Inc.

Auctus Biologics is a pre-clinical biotechnology company developing antibody mimetics for therapeutic and diagnostic applications.

Artificial Intelligence

Anthropic, Inc.

Anthropic is an AI safety and research company that’s working to build reliable, interpretable, and steerable AI systems.

Hebbia, Inc.

The leading AI platform for finance, used by the world’s leading asset managers, investment banks, law firms and Fortune 500 companies

Maket Technologies Inc.

Maket AI is a specialized, generative AI platform designed for the AEC (Architecture, Engineering, and Construction) and real estate industries to automate residential design and planning.

Healthcare

Revero, Inc.

Revero is a data-driven digital clinic with the mission to reverse autoimmune and other chronic diseases by addressing the root causes.

Companies shown represent past investments and are listed for informational purposes only. Ageless Fund Research Platform content is provided for general informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security. Investing involves risk, including possible loss of principal.